Cargando…
Advances in Toxoplasma gondii Vaccines: Current Strategies and Challenges for Vaccine Development
Toxoplasmosis, caused by the apicomplexan parasite Toxoplasma gondii, is one of the most damaging parasite-borne zoonotic diseases of global importance. While approximately one-third of the entire world’s population is estimated to be infected with T. gondii, an effective vaccine for human use remai...
Autores principales: | Chu, Ki-Back, Quan, Fu-Shi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8143161/ https://www.ncbi.nlm.nih.gov/pubmed/33919060 http://dx.doi.org/10.3390/vaccines9050413 |
Ejemplares similares
-
Parasite Infiltration and Apoptosis in Spleen upon Toxoplasma gondii Infection
por: Lee, Su-Hwa, et al.
Publicado: (2019) -
Virus-like Particle Vaccine Containing Toxoplasma gondii Rhoptry Protein 13 Induces Protection against T. gondii ME49 Infection in Mice
por: Kang, Hae-Ji, et al.
Publicado: (2019) -
Detection of Toxoplasma gondii Infections using Virus-Like Particles Displaying T. gondii ROP4 Antigen
por: Kim, Min-Ju, et al.
Publicado: (2021) -
Respiratory Viruses and Virus-like Particle Vaccine Development: How Far Have We Advanced?
por: Chu, Ki-Back, et al.
Publicado: (2023) -
Mucosal Administration of Recombinant Baculovirus Displaying Toxoplasma gondii ROP4 Confers Protection Against T. gondii Challenge Infection in Mice
por: Yoon, Keon-Woong, et al.
Publicado: (2021)